A study of NCAA Division I football players revealed persistent atrophy in the quadriceps and gastrocnemius muscles 2 years ...

Alterity Therapeutics Ltd. reported positive top-line phase II results for lead candidate ATH-434 for treating multiple ...

Health activists demand government action to reduce the cost of SMA medicines, citing constitutional obligations and ...

Australia's Therapeutic Goods Administration has approved the use of a new and first treatment for geographic atrophy - a disease which causes severe ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...